95 related articles for article (PubMed ID: 29555323)
1. The morphological changes of monocytes in peripheral blood as a potential indicator for predicting active pulmonary tuberculosis.
Shen T; Cao X; Shi J; Yu Y; Zhu Y; Gu D
Clin Chim Acta; 2018 Jun; 481():189-192. PubMed ID: 29555323
[TBL] [Abstract][Full Text] [Related]
2. Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy.
Chowdhury IH; Ahmed AM; Choudhuri S; Sen A; Hazra A; Pal NK; Bhattacharya B; Bahar B
Mol Immunol; 2014 Nov; 62(1):159-68. PubMed ID: 25019566
[TBL] [Abstract][Full Text] [Related]
3. Elevated HMGB1-related interleukin-6 is associated with dynamic responses of monocytes in patients with active pulmonary tuberculosis.
Zeng JC; Xiang WY; Lin DZ; Zhang JA; Liu GB; Kong B; Gao YC; Lu YB; Wu XJ; Yi LL; Zhong JX; Xu JF
Int J Clin Exp Pathol; 2015; 8(2):1341-53. PubMed ID: 25973018
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Diagnostic Efficacy of Monocyte Parameters and MCP-1 to Distinguishing Active Tuberculosis from Latent Tuberculosis.
Sun T; Wu B; Wang J; Yuan T; Huang H; Xu D; Shaoli ; Deng
Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307161
[TBL] [Abstract][Full Text] [Related]
5. VCS parameters of neutrophils, monocytes and lymphocytes may indicate local bacterial infection in cancer patients who accepted cytotoxic chemotherapeutics.
Zhou N; Liu L; Li D; Zeng Q; Song X
Eur J Clin Microbiol Infect Dis; 2016 Jan; 35(1):41-8. PubMed ID: 26563897
[TBL] [Abstract][Full Text] [Related]
6. [Serological diagnosis of pulmonary tuberculosis and nontuberculous pulmonary mycobacteriosis].
Kondo A; Oketani N; Maruyama M; Saito Y; Miyao H; Ohno M; Wada K; Tsuchiya T; Nagai T; Tsuchiya K; Watanabe Y
Kekkaku; 2001 Sep; 76(9):603-14. PubMed ID: 11676117
[TBL] [Abstract][Full Text] [Related]
7. Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia.
Qi ZJ; Yu H; Zhang J; Li CS
Clin Chim Acta; 2018 Mar; 478():152-156. PubMed ID: 29289622
[TBL] [Abstract][Full Text] [Related]
8. Leukocyte Cell Population Data (CPD) as a Discriminating Tool between Active Tuberculosis and Lung Cancer.
Sun T; Luo Z; Luo J; Deng S
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948483
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of mean monocyte volume in septicemia caused by
Kumar D; Sudha M; Tarai B; Das P
J Lab Physicians; 2018; 10(4):397-400. PubMed ID: 30498310
[TBL] [Abstract][Full Text] [Related]
10. The monocyte-to-lymphocyte ratio: Sex-specific differences in the tuberculosis disease spectrum, diagnostic indices and defining normal ranges.
Buttle TS; Hummerstone CY; Billahalli T; Ward RJB; Barnes KE; Marshall NJ; Spong VC; Bothamley GH
PLoS One; 2021; 16(8):e0247745. PubMed ID: 34460817
[TBL] [Abstract][Full Text] [Related]
11. Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages.
La Manna MP; Orlando V; Dieli F; Di Carlo P; Cascio A; Cuzzi G; Palmieri F; Goletti D; Caccamo N
PLoS One; 2017; 12(2):e0171358. PubMed ID: 28208160
[TBL] [Abstract][Full Text] [Related]
12. Changes in serum cytokine levels in active tuberculosis with treatment.
Deveci F; Akbulut HH; Turgut T; Muz MH
Mediators Inflamm; 2005 Oct; 2005(5):256-62. PubMed ID: 16258192
[TBL] [Abstract][Full Text] [Related]
13. Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.
Hasan Z; Zaidi I; Jamil B; Khan MA; Kanji A; Hussain R
BMC Immunol; 2005 Jul; 6():14. PubMed ID: 16001981
[TBL] [Abstract][Full Text] [Related]
14. The VCS parameters: Potential hematological indicators for predicting antituberculosis drug-induced neutropenia.
Shen T; Gu D; Zhu Y; Shi J; Xu D; Cao X
Clin Chim Acta; 2016 Aug; 459():147-149. PubMed ID: 27262821
[TBL] [Abstract][Full Text] [Related]
15. Predictors of Initial Smear-Negative Active Pulmonary Tuberculosis with Acute Early Stage Lung Injury by High-Resolution Computed Tomography and Clinical Manifestations: An Auxiliary Model in Critical Patients.
Yeh JJ
Sci Rep; 2019 Mar; 9(1):4527. PubMed ID: 30872774
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-tetrofosmin scintigraphy in pulmonary tuberculosis.
Degirmenci B; Kilinc O; Cirak KA; Capa G; Akpinar O; Halilcolar H; Durak H; Akkoclu A; Derebek E; Ucan ES
J Nucl Med; 1998 Dec; 39(12):2116-20. PubMed ID: 9867153
[TBL] [Abstract][Full Text] [Related]
17. The Novel Predictive Biomarkers for Type 2 Diabetes Mellitus in Active Pulmonary Tuberculosis Patients.
Yu Q; Weng W; Luo H; Yan J; Zhao X
Infect Drug Resist; 2022; 15():4529-4539. PubMed ID: 35992755
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of selective monocyte functions in tuberculosis.
Ellner JJ; Spagnuolo PJ; Schachter BZ
J Infect Dis; 1981 Nov; 144(5):391-8. PubMed ID: 6947016
[TBL] [Abstract][Full Text] [Related]
19. Generation of Mycobacterium tuberculosis-specific recombinant antigens and evaluation of the clinical value of antibody detection for serological diagnosis of pulmonary tuberculosis.
Zhang X; Su Z; Zhang X; Hu C; Yu J; Gao Q; Wang H
Int J Mol Med; 2013 Mar; 31(3):751-7. PubMed ID: 23338746
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a whole-blood chemiluminescent immunoassay of IFN-γ, IP-10, and MCP-1 for diagnosis of active pulmonary tuberculosis and tuberculous pleurisy patients.
Liang Y; Wang Y; Li H; Yang Y; Liu J; Yu T; Wu X
APMIS; 2016 Oct; 124(10):856-64. PubMed ID: 27523388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
